Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2016, Article ID 2683403, 7 pages
http://dx.doi.org/10.1155/2016/2683403
Research Article

Safety Evaluation of Unani Formulation: Capsule Shaqeeqa in Albino Wistar Rats

1Drug Standardisation Research Unit, Regional Research Institute of Unani Medicine, CCRUM, University of Kashmir, Naseem Bagh Campus, Srinagar 190006, India
2Department of Biochemistry, University of Kashmir, Srinagar, Jammu and Kashmir 190006, India
3Central Council for Research in Unani Medicine, New Delhi 110058, India

Received 30 December 2015; Revised 7 March 2016; Accepted 16 March 2016

Academic Editor: Evan P. Cherniack

Copyright © 2016 Khalid Ghazanfar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. G. Mustafa, B. A. Ganai, S. Akbar, M. Y. Dar, and A. Masood, “β-Cell protective efficacy, hypoglycemic and hypolipidemic effects of extracts of Achillea millifolium in diabetic rats,” Chinese Journal of Natural Medicines, vol. 10, no. 3, pp. 185–189, 2012. View at Publisher · View at Google Scholar
  2. K. Ghazanfar, B. A. Ganai, S. Akbar et al., “Antidiabetic activity of Artemisia amygdalina decne in streptozotocin induced diabetic rats,” BioMed Research International, vol. 2014, Article ID 185676, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Mubashir, K. Ghazanfar, B. A. Ganai, S. Akbar, A. H. Malik, and A. Masood, “Scientific validation of Gentiana kurroo royle for anti-inflammatory and immunomodulatory potential,” ISRN Inflammation, vol. 2014, Article ID 701765, 5 pages, 2014. View at Publisher · View at Google Scholar
  4. A. Gurib-Fakim, “Medicinal plants: traditions of yesterday and drugs of tomorrow,” Molecular Aspects of Medicine, vol. 27, no. 1, pp. 1–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. WHO, Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems, World Health Organization, Geneva, Switzerland, 2004.
  6. B. Saad, H. Azaizeh, G. Abu-Hijleh, and O. Said, “Safety of traditional Arab herbal medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 4, pp. 433–439, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. C. R. D. Colson and M. E. De Broe, “Kidney injury from alternative medicines,” Advances in Chronic Kidney Disease, vol. 12, no. 3, pp. 261–275, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. T. H. Kwan, M. K. H. Tong, K. T. Leung et al., “Acute renal failure associated with prolonged intake of slimming pills containing anthraquinones,” Hong Kong Medical Journal, vol. 12, no. 5, pp. 394–397, 2006. View at Google Scholar · View at Scopus
  9. Y. P. Zhu, “Toxicology of the Chinese herb mu tong (Aristolochia manshuriensis). What history tells us,” Adverse Drug React Toxicology Reviews, vol. 21, no. 4, pp. 171–177, 2002. View at Publisher · View at Google Scholar
  10. J.-L. Vanherweghem, “Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy),” Journal of Alternative and Complementary Medicine, vol. 4, no. 1, pp. 9–13, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Moritz, P. Compagnon, I. G. Kaliszczak, Y. Kaliszczak, V. Caliskan, and C. Girault, “Severe acute poisoning with homemade Aconitum napellus capsules: toxicokinetic and clinical data,” Clinical Toxicology, vol. 43, no. 7, pp. 873–876, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. R. S. Horowitz, K. Feldhaus, R. C. Dart, F. R. Stermitz, and J. J. Beck, “The clinical spectrum of Jin Bu Huan toxicity,” Archives of Internal Medicine, vol. 156, no. 8, pp. 899–903, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Benjamin, T. Muir, K. Briggs, and B. Pentland, “A case of cerebral haemorrhage—can Ginkgo biloba be implicated?” Postgraduate Medical Journal, vol. 77, no. 904, pp. 112–113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Ernst, “Serious psychiatric and neurological adverse effects of herbal medicines—a systematic review,” Acta Psychiatrica Scandinavica, vol. 108, no. 2, pp. 83–91, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. W. I. Jensen and J. P. Allen, “Naturally occurring and experimentally induced castor bean (Ricinus communis) poisoning in ducks,” Avian Diseases, vol. 25, no. 1, pp. 184–194, 1981. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Shetti, C. D. Kumar, N. K. Sriwastava, and I. P. Sharma, “Pharmacovigilance of herbal medicines: current state and future directions,” Pharmacognosy Magazine, vol. 7, no. 25, pp. 69–73, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Ghazanfar, S. A. Dar, T. Nazir, I. Ara, A. Masood, and S. Akbar, “Safety evaluation of polyherbal Unani formulation Deedan in Wistar rats,” Journal of Applied Pharmaceutical Science, vol. 5, no. 1, pp. 89–93, 2015. View at Publisher · View at Google Scholar
  18. S. A. Dar, K. Ghazanfar, S. Akbar et al., “Acute and sub-acute (28 days) oral toxicity studies of Deedan in Albino rats,” Journal of Applied Pharmaceutical Science, vol. 5, no. 4, pp. 107–114, 2015. View at Publisher · View at Google Scholar
  19. CCRUM, National Formulary of Unani Medicine, vol. 1, part 2, 2007.
  20. OECD, Guidelines for the Testing of Chemicals, Section 4 Test no. 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents, 1998.
  21. A. Riaz, R. A. Khan, S. Ahmed, and S. Afroz, “Assessment of acute toxicity and reproductive capability of a herbal combination,” Pakistan Journal of Pharmaceutical Sciences, vol. 23, no. 3, pp. 291–294, 2010. View at Google Scholar · View at Scopus
  22. H. H. S. Fong, “Integration of herbal medicine into modern medical practices: issues and prospects,” Integrative Cancer Therapies, vol. 1, no. 3, pp. 287–293, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Chan, “Some aspects of toxic contaminants in herbal medicines,” Chemosphere, vol. 52, no. 9, pp. 1361–1371, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. D. H. Phua, A. Zosel, and K. Heard, “Dietary supplements and herbal medicine toxicities—when to anticipate them and how to manage them,” International Journal of Emergency Medicine, vol. 2, no. 2, pp. 69–76, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Sireetawong, N. Lertprasertsuke, U. Srisawat et al., “Acuteandsub-chronictoxicity study of the water extract from Tiliacoratrianora Diels in rats,” Journal of Science and Technology, vol. 30, pp. 729–737, 2008. View at Google Scholar
  26. H. Olson, G. Betton, D. Robinson et al., “Concordance of the toxicity of pharmaceuticals in humans and in animals,” Regulatory Toxicology and Pharmacology, vol. 32, no. 1, pp. 56–67, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. A. A. Adeneye, O. P. Ajagbonna, T. I. Adeleke, and S. O. Bello, “Preliminary toxicity and phytochemical studies of the stem bark aqueous extract of Musanga cecropioides in rats,” Journal of Ethnopharmacology, vol. 105, no. 3, pp. 374–379, 2006. View at Publisher · View at Google Scholar · View at Scopus